Not sure about the demand in the US and EU but one thing I know for sure is that the Asian market will be booming for sure. A key reason is that Aus and NZ health-related products are highly sought after, due to geographical proximity and high quality. Also, the Asian markets are getting crowded with increasing number of upper middle income earners - people who can and are willing to pay a premium for this stuff. That was why A2M was doing so well - right product in right market at the right time.
I dont see anything different for this company - a lot of upsides but of course, need further contracts and financial information to validate down the road.
- Forums
- ASX - By Stock
- 4c fair value ($30M), 8c short term target ($60M)
Not sure about the demand in the US and EU but one thing I know...
-
- There are more pages in this discussion • 1,992 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NZS (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.334M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NZS (ASX) Chart |
Day chart unavailable